Compare TOI & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOI | BBCP |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | 641 | N/A |
| Industry | Medical/Nursing Services | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.4M | 345.5M |
| IPO Year | N/A | 2017 |
| Metric | TOI | BBCP |
|---|---|---|
| Price | $4.10 | $7.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $6.67 | ★ $8.25 |
| AVG Volume (30 Days) | ★ 1.4M | 98.0K |
| Earning Date | 05-07-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $392,867,000.00 |
| Revenue This Year | $30.15 | $4.90 |
| Revenue Next Year | $25.77 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.02 | $5.56 |
| 52 Week High | $4.88 | $8.13 |
| Indicator | TOI | BBCP |
|---|---|---|
| Relative Strength Index (RSI) | 63.16 | 38.68 |
| Support Level | $3.35 | $6.64 |
| Resistance Level | $4.15 | $7.29 |
| Average True Range (ATR) | 0.25 | 0.27 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 70.31 | 17.76 |
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators enables it to deliver concrete placement solutions. The company's operating segments include U.S. Concrete Pumping, U.K. Operations, and U.S. Concrete Waste Management Services, with the majority of revenue generated from the U.S. Concrete Pumping segment. Geographically, it operates in the United States and the United Kingdom, generating majority of its revenue from the United States.